Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	797.20	-273.22	30.45
Graham Fair Price	13.78	49.51	43.51
PEG	211.35	0.32	0.10
Price/Book	11.25	1.01	0.91
Price/Cash Flow	29.93	38.42	29.57
Prices/Earnings	-1.46	6.56	6.66
Price/Sales	15.48	3.23	2.80
Price/FCF	29.93	38.42	29.57
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-0.50	0.97	0.98
Operating Margin	-53.99	0.17	-0.37
ROA	40.96	< 0.005	< 0.005
ROE	0.03	0.04	12.90
ROIC	-0.07	0.03	-53.43
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	< 0.005	-57.13
Dividends QOQ	< 0.005	0.03	284.87
EBIT QOQ	-5.44	1.47	-72.98
EPS QOQ	0.65	0.21	-68.35
FCF QOQ	-0.18	-0.09	47.56
Revenue QOQ	0.02	0.02	17.96
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-68024.25	-50068.04	26.40
Days Sales Outstanding (DSO)	304.82	292.81	-3.94
Inventory Turnover	< 0.005	< 0.005	-35.86
Debt/Capitalization	0.26	0.25	-4.54
Quick Ratio	-5.21	-1.55	70.28
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	49.56	53.07	7.08
Cash	198.18	14.70	-92.58
Capex	-0.23	-0.15	37.38
Free Cash Flow	1.53	1.40	-8.31
Revenue	16.15	16.66	3.16
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	-0.10	-0.59	-477.74
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	8.27	-63.67	669.66
Naive Interpretation	Member

06 - Financial Health · Bad

Rating